07 Mar 2025 (Last Modified 31 Mar 2025)
Thank you for viewing our poster at #ACMT2025.
Discussions on Reddit about Mucuna pruriens (MP) are mainly about its use for self-treatment of Parkinson’s Disease (PD) and self-diagnosis.
Infrequent discussion of side effects or interactions with other medications, but frequent mention of the lack of regulation of herbal and dietary supplements (HDS) leading to unreliable dosing.
graph TD
A["Comments \n(n=13,612; 12,039 unique)"] --> B["Mentioning L-DOPA (n=688)"] & C["Mentioning MP (n=28)"]
B --> D["Unique & mentioning\n direct use of L-DOPA (n=688)"]
C --> E["Unique & mentioning\n direct use of MP (n=25)"]
Data Acquisition. Author MC wrote custom software in R and Python to extract all comments and posts from the subreddit r/Parkinson’s from the start of the subreddit to January 2025. The software is available on GitHub (requires invitation).
Data Preprocessing. We manually standardized comments, replacing brand names with generic names, expanded abbreviations, and corrected misspellings. We counted multiple identical posts by one user as one comment.
Data Analysis. Perception. We manually labelled each comment for (1) mentioning MP, (2) mentioning L-DOPA, (3) if the experience was positive, negative, neither, or both.
Perception. We manually labelled each comment for (1) mentioning MP, (2) mentioning L-DOPA, (3) if the experience was positive, negative, neither, or both.
Thematic Analysis. We conducted two rounds of qualitative analysis to identify themes in the post and then group post and comments by theme.
Fisher’s exact test P=0.384 |
Sentiment | |||
---|---|---|---|---|
Positive | Negative | Neither | ||
Substance | MP | 6 | 4 | 15 |
Substance | L-DOPA | 258 | 85 | 345 |
Users discuss the benefits, risks, and motivations for using MP in online forums.
Users turn to Mucuna:
The doses discussed of L-DOPA via MP are generally lower than L-DOPA via pharmaceuticals
Many comments discuss pharmacological properties and theoretical effects, not personal use
Next Steps.
Prospective observational cohort with testing of samples, like (Cohen et al., 2022). but with assessment of effect using Unified Parkinson’s Disease Rating Scale.
Similar study across multiple forums
Analysis of other compounds in MP that may potentiate L-DOPA or have disease-modifying effects